Practical guidelines for postmenopausal hormone therapy.
The fourth Amsterdam Menopause Symposium (2-4 October 2004) was dedicated to practical recommendations to guide clinicians after the confusion, concerns, and controversies generated by study results over the previous several years. Those recommendations are summarized in this deliberately concise and user-friendly document, always recognizing that each clinician must help women with their decision-making according to individual needs, desires, and understanding of benefits and risks.
Speroff
L
L
Oregon Health & Science University, Portland, OR 97239, USA. lsperoff@msn.com
Kenemans
P
P
Burger
H G
HG
D000544:Alzheimer Disease / Q000517:prevention & control; D001943:Breast Neoplasms / Q000139:chemically induced; D002318:Cardiovascular Diseases / Q000139:chemically induced; D015914:Estrogen Replacement Therapy / Q000009:adverse effects; D005260:Female; D006801:Humans; D015663:Osteoporosis, Postmenopausal / Q000517:prevention & control; D017698:Postmenopause; D017410:Practice Guidelines as Topic; D011372:Progestins / Q000008:administration & dosage / Q000009:adverse effects
D011372:Progestins